Millipore Sigma Vibrant Logo

341207 ET-18-OCH₃ - CAS 70641-51-9 - Calbiochem

View Products on Sigmaaldrich.com
341207
  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      CAS #Empirical Formula
      70641-51-9C₂₇H₅₈NO₆P
      Description
      OverviewA cell-permeable and reversible cytotoxic agent that shows selective cytocidal activity against neoplastic cells and virally transformed cells. Selectively inhibits phosphatidylinositol-specific phospholipase C (PI-PLC, IC50 = 9.6 µM) but does not inhibit phosphatidylcholine-specific PLC or PLD. Promotes apoptosis in mitogen-activated, but not resting, T lymphocytes in a dose- and time-dependent manner. Also promotes rapid and selective apoptosis in human leukemic cells.
      Catalogue Number341207
      Brand Family Calbiochem®
      SynonymsEdelfosine, 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphorylcholine
      References
      ReferencesHarguindey, J., et al. 2000. Apoptosis 5, 87.
      Cabaner, C., et al. 1999. Br. J. Pharmacol. 127, 813.
      Powis, G., and Phil, D. 1994. Cancer Metastasis Rev. 13, 91.
      Helfman, D., et al. 1993. Cancer Res. 53, 2955.
      Mollinedo, F., et al. 1993. Biochem. Biophys. Res. Commun. 192, 603.
      Powis, G., et al. 1992. Cancer Res. 52, 2835.
      Oishi, K., et al. 1988. Biochem. Biophys. Res. Commun. 157, 1000.
      Product Information
      CAS number70641-51-9
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₂₇H₅₈NO₆P
      Chemical formulaC₂₇H₅₈NO₆P
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPI-PLC
      Primary Target IC<sub>50</sub>9.6 µM against phosphatidylinositol-specific phospholipase C (PI-PLC)
      Purity≥95% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSYK0718000
      Safety Information
      R PhraseR: 40

      Limited evidence of a carcinogenic effect.
      S PhraseS: 22-36

      Do not breathe dust.
      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Carcinogenic / Teratogenic
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution in ethanol, aliquot and freeze (-20°C). Ethanol stock solutions are stable for up to 3 months at -20°C. Unstable in aqueous solution; reconstitute just prior to use.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      341207 0

      Documentation

      ET-18-OCH₃ - CAS 70641-51-9 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      ET-18-OCH₃ - CAS 70641-51-9 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      341207

      Références bibliographiques

      Aperçu de la référence bibliographique
      Harguindey, J., et al. 2000. Apoptosis 5, 87.
      Cabaner, C., et al. 1999. Br. J. Pharmacol. 127, 813.
      Powis, G., and Phil, D. 1994. Cancer Metastasis Rev. 13, 91.
      Helfman, D., et al. 1993. Cancer Res. 53, 2955.
      Mollinedo, F., et al. 1993. Biochem. Biophys. Res. Commun. 192, 603.
      Powis, G., et al. 1992. Cancer Res. 52, 2835.
      Oishi, K., et al. 1988. Biochem. Biophys. Res. Commun. 157, 1000.

      Posters

      Titre
      Human Kinome & InhibitorSelect™ Libraries
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision23-May-2011 JSW
      SynonymsEdelfosine, 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphorylcholine
      DescriptionA cell-permeable and reversible cytotoxic agent that shows selective cytocidal activity against neoplastic cells and virally transformed cells. Selectively inhibits phosphatidylinositol-specific phospholipase C (PI-PLC, IC50 = 9.6 µM) but does not inhibit phosphatidylcholine-specific PLC or PLD. Inhibits protein kinase C from various leukemic cells. Also promotes rapid and selective apoptosis in human leukemic cells. Has strong antitumor and anticancer properties.
      FormWhite solid
      CAS number70641-51-9
      RTECSYK0718000
      Chemical formulaC₂₇H₅₈NO₆P
      Structure formulaStructure formula
      Purity≥95% by TLC
      SolubilityDMSO (5 mg/ml), CHCl₃ (50 mg/ml), Ethanol (5 mg/ml), or H₂O. Material may form micelles in aqueous stock solutions, which may affect experimental results.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution in ethanol, aliquot and freeze (-20°C). Ethanol stock solutions are stable for up to 3 months at -20°C. Unstable in aqueous solution; reconstitute just prior to use.
      Toxicity Carcinogenic / Teratogenic
      ReferencesHarguindey, J., et al. 2000. Apoptosis 5, 87.
      Cabaner, C., et al. 1999. Br. J. Pharmacol. 127, 813.
      Powis, G., and Phil, D. 1994. Cancer Metastasis Rev. 13, 91.
      Helfman, D., et al. 1993. Cancer Res. 53, 2955.
      Mollinedo, F., et al. 1993. Biochem. Biophys. Res. Commun. 192, 603.
      Powis, G., et al. 1992. Cancer Res. 52, 2835.
      Oishi, K., et al. 1988. Biochem. Biophys. Res. Commun. 157, 1000.